Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 2,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Autism Spectrum Disorder
Interventions: Care Coordination Visit; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 14 Years to 19 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Anxiety Acute, Stress, Depression and Quality of Life, Stress in Parents of Autistic Children
Interventions: Group Drumming; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Neurodevelopmental Disorders, Autism Spectrum Disorder (ASD), Attention-Deficit/Hyperactivity Disorder (ADHD), Intellectual Disability, Learning Disorder, Communication Disorders, Down Syndrome, Fragile X Syndrome, Motor Tic Disorders
Interventions: EMPOWER-ND; Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention Deficit/Hyperactivity Disorder
Interventions: centanafadine capsule, placebo capsule; Drug · Other
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 4 Years to 12 Years
Enrollment: 574 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Autism Spectrum Disorder
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 6 Years to 11 Years
Enrollment: 265 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Modafinil; Drug
Lead sponsor: Cephalon; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 23
States / cities: Little Rock, Arkansas • Irvine, California • San Francisco, California + 20 more

Conditions: Autism Spectrum Disorder
Interventions: Stay-Play-Talk Basic, Stay-Play-Talk Plus, Stay-Play-Talk Advanced; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 3 Years to 6 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Kansas City, Kansas • Chapel Hill, North Carolina

Conditions: Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions: HLD100; Drug
Lead sponsor: Ironshore Pharmaceuticals and Development, Inc; Other
Eligibility: 6 Years to 12 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Attention Deficit Hyperactivity Disorder, Substance Abuse
Interventions: Atomoxetine, Placebo; Drug
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 12 Years to 19 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: NRCT-101SR; Drug
Lead sponsor: Neurocentria, Inc.; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 13
States / cities: Anaheim, California • Lakeland, Florida • Maitland, Florida + 10 more

Conditions: Noncompliance
Interventions: Parent Child Interaction Therapy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 30 Months to 83 Months
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Health Literacy, Attention Deficit Disorder With Hyperactivity, Computer Literacy, Information Management, Parents
Interventions: Use of paper forms to write down information, Computer; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 194 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Disruptive Behavior, Developmental Disability, Developmental Delay (Disorder), Behavior Problem of Childhood
Interventions: DOCS Parenting: Early Years, DOCS Parenting: School Years; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Autism Spectrum Disorder
Interventions: N-acetylcysteine; Drug
Lead sponsor: Stanford University; Other
Eligibility: 3 Years to 13 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Stanford, California

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: atomoxetine, Behavior Modification Therapy; Drug · Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 6 Years to 12 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Autism Spectrum Disorder (ASD)
Interventions: Omega-3 Fatty Acid; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 17 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Infant, Newborn, Infant, Small for Gestational Age, Infant, Extremely Low Birth Weight
Interventions: Donor Milk, Preterm Formula; Biological · Dietary Supplement
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 21 Days
Enrollment: 483 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • Atlanta, Georgia + 13 more

Conditions: Autism Spectrum Disorder, Intellectual Disability
Interventions: Individualized Placement and Support Model, Supportive Employment Intervention; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Intellectual Disability, Mild to Moderate, Developmental Disability
Interventions: Ready to Ride - Standard Delivery, Ready to Ride - Peer Support Delivery; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 27 Years
Enrollment: 325 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Gainesville, Florida • Minneapolis, Minnesota • Durham, New Hampshire

Conditions: ADHD, Bipolar Disorder
Interventions: methylphenidate HCl (Concerta); Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 55 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Autism
Interventions: Trichuris Suis Ova; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 35 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Autism
Interventions: CM-AT, Placebo; Drug
Lead sponsor: Curemark; Industry
Eligibility: 3 Years to 8 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 19
States / cities: Phoenix, Arizona • Sacramento, California • San Francisco, California + 16 more

Conditions: Asperger's Disorder, Mental Retardation, Children, Adult, Autism Spectrum Disorders
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 5 Years to 89 Years
Enrollment: 678 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Homework, Organization, and Planning Skills (HOPS) Intervention; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 11 Years to 15 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Cincinnati, Ohio

Search by objective public record fields.

Effectiveness of the Care Coordination, Assessment, and Responsive Engagement Program for Transition-aged Adolescents (t-CARE) With ASD

Drumming Groups for Parents of Autistic Children

Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance

A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)

Autism Biomarker Consortium for Clinical Trials (ABC-CT): Follow-up Study

Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

Peer Interventions for Preschoolers With Autism

A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD

Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder

Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD

Efficacy of Parent-Child Interaction Therapy With Autism Spectrum Disorder

Parents at the Center: Information Management in ADHD - Clinical Trial

Behavioral Parent Training to Address Early Childhood Disruptive Behavior Using the DOCS Parenting Programs

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label

Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD

Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders

Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants

Testing an Evidence-Based Supported Employment Model in Autistic Young Adults

Comparing the Impact of Peer Support vs. Staff-Delivered Transportation Interventions for Young Adults With Intellectual and Developmental Disabilities.

Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder

Trichuris Suis Ova in Autism Spectrum Disorders

A Trial of CM-AT in Children With Autism

Cognitive Neuroscience of Autism Spectrum Disorders

Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD)